BRPI0806964A2 - Combinações de agonístico beta-2-adrenoceptor e benzotiazolona - Google Patents

Combinações de agonístico beta-2-adrenoceptor e benzotiazolona

Info

Publication number: BRPI0806964A2
Authority: BR; Brazil
Prior art keywords: benzotiazolone; adrenoceptor; agonistic; beta; combinations
Prior art date: 2007-02-08

Application number

BRPI0806964-6A2A

Other languages

English (en)

Inventor

Elaine Bridget Cadogan

Stephen Connolly

David John Nicholls

Katherine Elisabeth Wiley

Alan Young

Original Assignee

Astrazeneca Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-02-08

Filing date

2008-02-06

Publication date

2014-04-08

2008-02-06 Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab

2014-04-08 Publication of BRPI0806964A2 publication Critical patent/BRPI0806964A2/pt

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/428—Thiazoles condensed with carbocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
Pulmonology (AREA)
Bioinformatics & Cheminformatics (AREA)
Otolaryngology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

BRPI0806964-6A2A 2007-02-08 2008-02-06 Combinações de agonístico beta-2-adrenoceptor e benzotiazolona BRPI0806964A2 (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB0702456.5A GB0702456D0 (en)	2007-02-08	2007-02-08	New combination
PCT/GB2008/000386 WO2008096111A1 (en)	2007-02-08	2008-02-06	Combinations of beta- 2 -adrenoceptor agonistic benzothiazolone

Publications (1)

Publication Number	Publication Date
BRPI0806964A2 true BRPI0806964A2 (pt)	2014-04-08

Family

ID=37898976

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0806964-6A2A BRPI0806964A2 (pt)	2007-02-08	2008-02-06	Combinações de agonístico beta-2-adrenoceptor e benzotiazolona

Country Status (29)

Country	Link
US (2)	US20100029732A1 (pt)
EP (2)	EP2117542B1 (pt)
JP (1)	JP2010518056A (pt)
KR (1)	KR20090114391A (pt)
CN (1)	CN101652137A (pt)
AR (1)	AR065277A1 (pt)
AT (1)	ATE520401T1 (pt)
AU (1)	AU2008212713A1 (pt)
BR (1)	BRPI0806964A2 (pt)
CA (1)	CA2675465A1 (pt)
CL (1)	CL2008000379A1 (pt)
CO (1)	CO6210723A2 (pt)
CY (1)	CY1111932T1 (pt)
DK (1)	DK2117542T3 (pt)
EC (1)	ECSP099567A (pt)
ES (1)	ES2368967T3 (pt)
GB (1)	GB0702456D0 (pt)
HR (1)	HRP20110695T1 (pt)
IL (1)	IL199840A0 (pt)
MX (1)	MX2009007865A (pt)
PE (1)	PE20081759A1 (pt)
PL (1)	PL2117542T3 (pt)
PT (1)	PT2117542E (pt)
RS (1)	RS51956B (pt)
RU (1)	RU2009133255A (pt)
SI (1)	SI2117542T1 (pt)
TW (1)	TW200843750A (pt)
UY (1)	UY30906A1 (pt)
WO (1)	WO2008096111A1 (pt)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TW200738658A (en)	2005-08-09	2007-10-16	Astrazeneca Ab	Novel compounds
TW200738659A (en) *	2005-08-29	2007-10-16	Astrazeneca Ab	Novel compounds
TW200745067A (en)	2006-03-14	2007-12-16	Astrazeneca Ab	Novel compounds
TW200825084A (en)	2006-11-14	2008-06-16	Astrazeneca Ab	New compounds 521
TW200833670A (en) *	2006-12-20	2008-08-16	Astrazeneca Ab	Novel compounds 569
GB0702458D0 (en)	2007-02-08	2007-03-21	Astrazeneca Ab	Salts 668
BRPI0822693A2 (pt)	2008-05-13	2015-07-07	Astrazeneca Ab	Derivados de quinuclidina como antagonistas do receptor muscarínico m3
KR20110010725A (ko) *	2008-05-13	2011-02-07	아스트라제네카 아베	무스카린성 수용체 길항제 및 β２아드레날린수용체 효능제를 포함하는 제약 생성물
CA2726746A1 (en)	2008-06-18	2009-12-23	Astrazeneca Ab	Benzoxazinone derivatives acting as beta2-adrenoreceptor agonist for the treatment of respiratory disorders
UY31920A (es) *	2008-06-20	2010-01-29	Astrazeneca Ab	Nueva combinacion-408
TW201036957A (en)	2009-02-20	2010-10-16	Astrazeneca Ab	Novel salt 628
US9827212B2 (en)	2009-03-18	2017-11-28	The Trustees Of The University Of Pennsylvania	Compositions and methods for treating asthma and other lung diseases
US10265311B2 (en)	2009-07-22	2019-04-23	PureTech Health LLC	Methods and compositions for treatment of disorders ameliorated by muscarinic receptor activation
EP3646870A1 (en)	2009-07-22	2020-05-06	Puretech Health LLC	Methods and compositions for treatment of disorders ameliorated by muscarinic receptor activation
WO2011061527A1 (en)	2009-11-17	2011-05-26	Astrazeneca Ab	Combinations comprising a glucocorticoid receptor modulator for the treatment of respiratory diseases
GB201016912D0 (en)	2010-10-07	2010-11-24	Astrazeneca Ab	Novel combination
MA50680A (fr)	2014-09-09	2020-08-05	Vectura Ltd	Formulation comprenant glycopyrrolate, procédé et appareil
US10183947B2 (en) *	2015-05-04	2019-01-22	Astrazeneca Ab	Pyrazole derivatives useful as 5-lipoxygenase activating protein (FLAP) inhibitors
EP3856182B1 (en)	2018-09-28	2025-12-24	Karuna Therapeutics, Inc.	Compositions and methods for treating disorders ameliorated by muscarnic receptor activation

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE378109B (pt)	1972-05-19	1975-08-18	Bofors Ab
ES2165768B1 (es)	1999-07-14	2003-04-01	Almirall Prodesfarma Sa	Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
CO5300399A1 (es)	2000-02-25	2003-07-31	Astrazeneca Ab	Heterocicliocs que contienen nitrogeno, proceso para su preparacion y composiciones farmaceuticas que los contienen
AR028948A1 (es)	2000-06-20	2003-05-28	Astrazeneca Ab	Compuestos novedosos
SE0100902D0 (sv)	2001-03-15	2001-03-15	Astrazeneca Ab	Compounds
SE0104251D0 (sv)	2001-12-14	2001-12-14	Astrazeneca Ab	Novel compounds
SE0301569D0 (sv)	2003-05-27	2003-05-27	Astrazeneca Ab	Novel compounds
SA04250253B1 (ar)	2003-08-21	2009-11-10	استرازينيكا ايه بي	احماض فينوكسي اسيتيك مستبدلة باعتبارها مركبات صيدلانية لعلاج الامراض التنفسية مثل الربو ومرض الانسداد الرئوي المزمن
SE0302486D0 (sv)	2003-09-18	2003-09-18	Astrazeneca Ab	Novel compounds
GB0324790D0 (en)	2003-10-24	2003-11-26	Astrazeneca Ab	Amide derivatives
GB0402797D0 (en) *	2004-02-09	2004-03-10	Novartis Ag	Organic compounds
SE0401762D0 (sv)	2004-07-05	2004-07-05	Astrazeneca Ab	Novel compounds
CA2583428A1 (en)	2004-09-03	2006-03-09	Plexxikon, Inc.	Bicyclic heteroaryl pde4b inhibitors
KR20070068432A (ko)	2004-10-29	2007-06-29	아스트라제네카 아베	염증 질환의 치료를 위한 글루코코르티코이드 수용체조절제로서의 신규 술폰아미드 유도체
JPWO2006098353A1 (ja)	2005-03-15	2008-08-28	協和醗酵工業株式会社	外用剤
TW200738658A (en) *	2005-08-09	2007-10-16	Astrazeneca Ab	Novel compounds
JP2009543860A (ja)	2006-07-19	2009-12-10	アストラゼネカ・アクチエボラーグ	新規三環系スピロピペリジン化合物、それらの合成およびケモカイン受容体活性モジュレーターとしてのそれらの使用

2007
- 2007-02-08 GB GBGB0702456.5A patent/GB0702456D0/en not_active Ceased
2008
- 2008-02-04 TW TW097104221A patent/TW200843750A/zh unknown
- 2008-02-06 JP JP2009548730A patent/JP2010518056A/ja not_active Withdrawn
- 2008-02-06 HR HR20110695T patent/HRP20110695T1/hr unknown
- 2008-02-06 BR BRPI0806964-6A2A patent/BRPI0806964A2/pt not_active IP Right Cessation
- 2008-02-06 EP EP08702047A patent/EP2117542B1/en active Active
- 2008-02-06 RS RS20110435A patent/RS51956B/sr unknown
- 2008-02-06 KR KR1020097016587A patent/KR20090114391A/ko not_active Withdrawn
- 2008-02-06 US US12/526,328 patent/US20100029732A1/en not_active Abandoned
- 2008-02-06 AT AT08702047T patent/ATE520401T1/de active
- 2008-02-06 SI SI200830397T patent/SI2117542T1/sl unknown
- 2008-02-06 CN CN200880010926A patent/CN101652137A/zh active Pending
- 2008-02-06 DK DK08702047.5T patent/DK2117542T3/da active
- 2008-02-06 EP EP11163020A patent/EP2364704A1/en not_active Withdrawn
- 2008-02-06 CL CL200800379A patent/CL2008000379A1/es unknown
- 2008-02-06 ES ES08702047T patent/ES2368967T3/es active Active
- 2008-02-06 CA CA002675465A patent/CA2675465A1/en not_active Abandoned
- 2008-02-06 MX MX2009007865A patent/MX2009007865A/es not_active Application Discontinuation
- 2008-02-06 AU AU2008212713A patent/AU2008212713A1/en not_active Abandoned
- 2008-02-06 PL PL08702047T patent/PL2117542T3/pl unknown
- 2008-02-06 WO PCT/GB2008/000386 patent/WO2008096111A1/en not_active Ceased
- 2008-02-06 PT PT08702047T patent/PT2117542E/pt unknown
- 2008-02-06 RU RU2009133255/15A patent/RU2009133255A/ru not_active Application Discontinuation
- 2008-02-07 US US12/027,424 patent/US20080242649A1/en not_active Abandoned
- 2008-02-07 PE PE2008000269A patent/PE20081759A1/es not_active Application Discontinuation
- 2008-02-08 AR ARP080100560A patent/AR065277A1/es not_active Application Discontinuation
- 2008-02-08 UY UY30906A patent/UY30906A1/es unknown
2009
- 2009-07-13 IL IL199840A patent/IL199840A0/en unknown
- 2009-07-21 CO CO09075448A patent/CO6210723A2/es not_active Application Discontinuation
- 2009-08-06 EC EC2009009567A patent/ECSP099567A/es unknown
2011
- 2011-10-12 CY CY20111100976T patent/CY1111932T1/el unknown

Also Published As

Publication number	Publication date
EP2117542B1 (en)	2011-08-17
PT2117542E (pt)	2011-10-06
RS51956B (sr)	2012-02-29
GB0702456D0 (en)	2007-03-21
DK2117542T3 (da)	2011-10-31
ES2368967T3 (es)	2011-11-24
UY30906A1 (es)	2008-09-30
WO2008096111A1 (en)	2008-08-14
TW200843750A (en)	2008-11-16
AR065277A1 (es)	2009-05-27
SI2117542T1 (sl)	2011-11-30
PL2117542T3 (pl)	2011-12-30
CN101652137A (zh)	2010-02-17
KR20090114391A (ko)	2009-11-03
EP2117542A1 (en)	2009-11-18
US20080242649A1 (en)	2008-10-02
CO6210723A2 (es)	2010-10-20
IL199840A0 (en)	2010-04-15
ATE520401T1 (de)	2011-09-15
RU2009133255A (ru)	2011-03-20
JP2010518056A (ja)	2010-05-27
PE20081759A1 (es)	2009-01-31
AU2008212713A1 (en)	2008-08-14
US20100029732A1 (en)	2010-02-04
HRP20110695T1 (hr)	2011-11-30
CY1111932T1 (el)	2015-11-04
CL2008000379A1 (es)	2008-10-24
ECSP099567A (es)	2009-09-29
MX2009007865A (es)	2009-07-31
CA2675465A1 (en)	2008-08-14
EP2364704A1 (en)	2011-09-14

Publication	Publication Date	Title
BRPI0806964A2 (pt)	2014-04-08	Combinações de agonístico beta-2-adrenoceptor e benzotiazolona
BRPI0818380A2 (pt)	2014-10-07	Combinação de herbicida-protetor
EP2212691A4 (en)	2015-09-23	MICROCHIP
BRPI0907231A2 (pt)	2019-09-24	pirrolpirimidinas e pirrolpiridinas
CR10841A (es)	2009-06-30	Imidazotriazinas imidazopirimidinas inhibidores de cinasa
BRPI0821573A2 (pt)	2016-08-09	benzofuropirimidonas
ATE501136T1 (de)	2011-03-15	Imidazopyridinone
DE502007001207D1 (de)	2009-09-10	Elektrosaugkopf
HRP20170963T1 (hr)	2017-09-22	Modificirani saharidi
ATE514696T1 (de)	2011-07-15	Diphenyl-dihydro-imidazopyridinone
DK2178568T3 (da)	2014-07-21	Kontrastmidler
DE112008003636A5 (de)	2010-10-21	Mehrzuggruppierer
BRPI0807911A2 (pt)	2014-06-17	Agonistas de alfa2c adrenorreceptor
BRPI0814519A2 (pt)	2014-09-30	Organopolissiloxano
BRPI0811451A2 (pt)	2014-11-04	Exopolissacarídeo
BRPI0815547A2 (pt)	2015-02-10	Depsipeptídeos cícliocos
BRPI0812840A2 (pt)	2014-12-09	2-imidazolinas
DK2155273T3 (da)	2013-04-22	Lugtregulerende genstand
BRPI0812994A2 (pt)	2014-12-23	Microbiocidas
AT505058A3 (de)	2008-12-15	Türschliesssystem
DE112008001216A5 (de)	2010-02-04	Magnetronplasmaanlage
DE502008001694D1 (de)	2010-12-16	Mitfahrhubwagen
DE112008003094A5 (de)	2010-08-12	Geomatte
ATE506032T1 (de)	2011-05-15	Endoprothesenkomponente
DE112008003196A5 (de)	2011-02-03	Handpipettiergerät

Legal Events

Date	Code	Title	Description
2014-08-26	B08L	Patent application lapsed because of non payment of annual fee [chapter 8.12 patent gazette]	Free format text: REFERENTE AO NAO RECOLHIMENTO DAS 5A E 6A ANUIDADES.
2020-11-10	B08I	Publication cancelled [chapter 8.9 patent gazette]	Free format text: ANULADA A PUBLICACAO CODIGO 8.12 NA RPI NO 2277 DE 26/08/2014 POR TER SIDO INDEVIDA.
2020-11-17	B08F	Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]	Free format text: REFERENTE AS 5A, 6A, 7A, 8A, 9A, 10A, 11A E 12A ANUIDADES.
2021-03-09	B08K	Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]	Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2602 DE 17-11-2020 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.